Skip to Main Content

Paper Details

Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial.
J Clin Oncol
30
2023
Author NameAffiliation
Jeeyun LeeSamsung Medical Center Sungkyunkwan University School of Medicine
  • 1 - 1

Datasets

Release 1.2